PIM
RMD icon

Penobscot Investment Management’s ResMed RMD Stock Holding History

Penobscot Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$435K Sell
2,234
-460
-17% -$95.3K 0.03% 233
2026
Q1 		$605K Buy
2,694
+220
+9% +$54.8K 0.05% 204
2025
Q4 		$596K Buy
2,474
+230
+10% +$58.8K 0.04% 204
2025
Q3 		$614K Buy
+2,244
New +$613K 0.05% 203

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CISOA
Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Penobscot Investment Management's RMD Position: Q2 2026 in Review

Penobscot Investment Management reduced its ResMed (RMD) stake by 17% in Q2 2026, selling an estimated $95.3K and leaving 2,234 shares worth $435K. The position accounts for 0.03% of the portfolio, ranked #233.

Penobscot Investment Management first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $614K in Q3 2025. 196 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Penobscot Investment Management held 2,234 shares of ResMed worth $435K as of Q2 2026.
  • Penobscot Investment Management sold 460 ResMed shares in Q2 2026, an estimated $95.3K.
  • ResMed made up 0.03% of Penobscot Investment Management's portfolio in Q2 2026, its #233 holding.
  • Penobscot Investment Management first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • Penobscot Investment Management's ResMed position peaked at $614K in Q3 2025.
  • 196 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.